Glycyl-N-[2-(acetylsulfanyl)ethyl]glycinamide trifluoroacetate (1:1), with the CAS number 97314-22-2, is a synthetic compound that features a combination of amino acid derivatives and a trifluoroacetate moiety. This substance is characterized by its unique structure, which includes a glycyl group and an acetylsulfanyl ethyl side chain, contributing to its potential biological activity. The trifluoroacetate component enhances its solubility and stability in various solvents, making it suitable for biochemical applications. The presence of sulfur in the acetylsulfanyl group may impart specific reactivity and interaction capabilities, particularly in biological systems. As a compound derived from amino acids, it may exhibit properties relevant to peptide synthesis, drug design, or as a biochemical probe. Its stability, solubility, and reactivity are essential for its application in research and potential therapeutic contexts. However, detailed studies on its pharmacological properties and biological effects would be necessary to fully understand its utility in scientific and medical fields.

glycyl-N-[2-(acetylsulfanyl)ethyl]glycinamide trifluoroacetate (1:1)

Find at CymitQuimica all products linked to CAS 97314-22-2. Enter now to get more information

N-Glycylglycyl-S-Acetylcysteamine Trifluoroacetate (GGACT) is a radioprotective agent that can be used for the protection of intestinal tissues during radiation therapy. GGACT is given intravenously, and is not absorbed from the intestine. It interacts with irradiated cells, which leads to the death of these cells by way of apoptosis. GGACT also has an effect on the nucleus and increases proton production in cells during irradiation. GGACT also protects against radiation-induced cell deformation, as it protects against DNA damage and oxidative stress.

CAS 97314-22-2: glycyl-N-[2-(acetylsulfanyl)ethyl]glycinamide trifluoroacetate (1:1)

N-Glycylglycyl-S-Acetylcysteamine Trifluoroacetate

Ref: 3D-FG92025